Our firm represented an international investment manager 3i in its first direct investment in Israel – the acquisition of the entire share capital of DSL.
DSL, a former centerpiece of the Kibbutz Degania Bet industry, is a leading manufacturer of medical catheters serving a global base of medical device OEM customers. DSL specializes in a wide range of intravascular catheters and medical devices in the cardiovascular and vascular, thoracic and general surgery, urology, critical care and operating rooms and enteral feeding markets. Founded in 1984, DSL is headquartered in Israel and has approximately 1,700 employees worldwide.
3i was established by the UK government in 1945, as a long-term investment fund. In 1994, 3i floated on the London Stock Exchange, and entered into the leading FTSE 100 Index. Currently, with approximately £13.5bn of assets under management, 3i operates mainly in Europe, Asia and North America, focusing on private equity (including investments in the healthcare and pharmaceutical industries), infrastructure and debt management.
Handled by:
Deal Team: Avraham Well, Nitzan Sandor, Sharon Rosen, Nadav Oberman, Ariel Mazer;
Real Estate Team: Michal Faktor, Elad Shulman, Ortal Rath, Ortal Nener, Moran Malul;
Tax and Government Grants Team: Anat Shavit, Namma Gil, Keren Alon, Idan Lange;
Labor Law Team: Naama Moshe, Amit Beker;
IP Team: Amit Dat, Kobi Barkan;
Environmental Law, Financing and Other: Eldad Meller, Avia Dallal, Evyatar Semo.
